| Nov 18 |
Eyenovia Stock Tumbles on Termination of Phase III Myopia Study
|
| Nov 18 |
Is Pfizer Inc. (PFE) the Best Immunotherapy Stock to Buy Now?
|
| Nov 18 |
ALNY Reports Sustained 6-Month Efficacy Data From Amyloidosis Study
|
| Nov 18 |
2 High-Yield Dividend Stocks I Can't Stop Buying
|
| Nov 18 |
FDA endorses speedy approval path for Regenxbio Duchenne gene therapy
|
| Nov 16 |
The weight-loss frenzy is making some pharma stocks much more volatile. Will the drama continue?
|
| Nov 15 |
How analysts are reacting to RFK Jr. as Trump's HHS pick
|
| Nov 15 |
Large pharmas, biotechs down as industries grapple with RFK Jr. at HHS
|
| Nov 15 |
Stock Of The Day: Is Pfizer Set Up To Rally?
|
| Nov 15 |
Big Pharma Reckoning Looms With RFK Jr. Eyeing Pfizer
|
